# Disposition and effects of alpha-pyrrolidinoisohexanophenone (α-PHiP) in comparison with cocaine: an observational study

**Authors:** Georgina De la Rosa, Giorgia Iacobone, Esther Papaseit, Olga Hladun, Lourdes Poyatos, Dolly Andrea Caicedo, Martha Catalina Argote, Soraya Martín, Mireia Ventura, Alessandro Di Giorgi, Silvia Graziano, Simona Pichini, Emilia Marchei, Magí Farré, Clara Pérez-Mañá

PMC · DOI: 10.3389/fphar.2025.1728824 · Frontiers in Pharmacology · 2026-01-14

## TL;DR

This study compares the effects and distribution of α-PHiP, a synthetic stimulant, to cocaine in humans, finding similar subjective effects but differences in physiological responses.

## Contribution

The study provides the first detailed pharmacokinetic and subjective effect profile of α-PHiP compared to cocaine in humans.

## Key findings

- α-PHiP was rapidly absorbed and had a short half-life of 1.1 hours.
- Subjective effects of α-PHiP were similar to cocaine but with lower intensity ratings.
- α-PHiP caused increased heart rate and more sustained blood pressure elevation compared to cocaine.

## Abstract

Alpha-pyrrolidinoisohexanophenone (α-PHiP) is a synthetic cathinone structurally related to alpha-pyrrolidinopentiophenone (α-PVP) and other pyrrolidinophenones, acting as a potent monoamine transporter inhibitor. Despite its raising prevalence on the recreational drug market, limited data exist about its human pharmacology. This study aimed to assess its concentrations in different matrices and characterize its acute effects in humans in comparison with cocaine when administered by intranasal route.

A non-controlled observational study was conducted under naturalistic conditions in seventeen healthy adults (nine men, eight women) with prior experience using psychostimulants. Participants self-administered intranasal doses of 15–25 mg α-PHiP or 75–90 mg cocaine in two separate sessions. Physiological parameters and subjective effects (VAS, ARCI, and VESSPA-SSE questionnaires) were assessed repeatedly at baseline and up to 5 h post-administration. Biological samples (oral fluid, urine, sweat), were collected to evaluate concentration-time profiles, including a time point of dried blood spot.

α-PHiP was rapidly absorbed, reaching maximum concentrations in oral fluid at 20 min and showed a short half-life (1.1 h). The amount excreted unchanged in urine or present in sweat was less than 1%. Dried blood spot levels showed high interindividual variability in the range of intoxication cases. Both α-PHiP and cocaine increased heart rate while the increase in blood pressure was more sustained for α-PHiP. Subjective effects of α-PHiP peaked within the first hour and were very similar to those of cocaine, being the feelings of high and intensity reported lower.

This study provides novel insights into the effects and distribution of α-PHiP across various biological matrices. α-PHiP elicited prototypical subjective effects characteristic of psychostimulants, confirming its potential for abuse. Compared to cocaine, α-PHiP produced similar subjective effects. Future research should further investigate the detection of its metabolites to improve monitoring and understanding of its pharmacokinetics.

## Linked entities

- **Chemicals:** alpha-pyrrolidinoisohexanophenone (PubChem CID 59809191), cocaine (PubChem CID 2826)

## Full-text entities

- **Genes:** SLC18A2 (solute carrier family 18 member A2) [NCBI Gene 6571] {aka PKDYS2, SVAT, SVMT, VAT2, VMAT2}
- **Chemicals:** cocaine (MESH:D003042), Alpha-pyrrolidinoisohexanophenone (-), alpha-PVP (MESH:C000592273), cathinone (MESH:C023665)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12848320/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12848320/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12848320/full.md

---
Source: https://tomesphere.com/paper/PMC12848320